← Leaderboards
Kimford J Meador
Medical College Of Georgia (Mcg)
$23,953,318
Attributed
$40,522,598
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,522,598 · 9
By mechanism
U01$27,658,468 · 1
R01$11,980,167 · 1
R61$564,126 · 1
U10$288,839 · 1
M01$30,998 · 5
Top collaborators
- Page Buckhannan Pennell12 shared
- Abigail Goren Matthews3 shared
- Julie A Kable2 shared
- Ryan May2 shared
- Alexandre Esteves Medina2 shared
Others in their field
Top investigators on “Epilepsy”
- Karen Wilcox · University Of Utah$40,784,208
- Mark J Daly · Broad Institute, Inc.$39,233,325
- Wayne N. Frankel · Jackson Laboratory$37,394,025
- Shlomo Shinnar · Montefiore Medical Center (Bronx, Ny)$34,999,274
- Christopher A Walsh · Beth Israel Deaconess Medical Center$34,874,606
- Stacey Gabriel · Massachusetts Institute Of Technology$34,637,180
Research focus
EpilepsyFutureDesignInvestigationChildCognitiveAffectSeizuresPregnancyWomanMothersDrug ExposureIn UteroAnticonvulsantsPregnant WomenGrantLamotrigineExposure ToFemale Of Child Bearing AgeAntiepileptic AgentsNeurodevelopmentProspectiveCohortNeuropsychology
Grant awards (31)
Vinpocetine Mediation of Prior Fetal Alcohol Exposure$201,530
R61 · FY2025 · AA · contact PI
Vinpocetine Mediation of Prior Fetal Alcohol Exposure$362,596
R61 · FY2024 · AA · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$1,924,297
U01 · FY2022 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,576,269
U01 · FY2021 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,180,681
U01 · FY2020 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,902,630
U01 · FY2019 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,599,894
U01 · FY2018 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$121,409
U01 · FY2017 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,171,989
U01 · FY2016 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$1,128,930
U01 · FY2015 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,844,126
U01 · FY2014 · NS · contact PI
Investigates the metabolomic indicators of neurodevelop risk in children of pregnant women with epilepsy$176,309
U01 · FY2014 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$2,860,622
U01 · FY2013 · NS · contact PI
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)$3,171,312
U01 · FY2012 · NS · contact PI
Emory Clinical Research Site for NEXT$288,839
U10 · FY2011 · NS · contact PI
Neurodevelopmental Effects of Antiepileptic Drugs II$878,590
R01 · FY2009 · NS · contact PI
Neurodevelopmental Effects of Antiepileptic Drugs II$846,816
R01 · FY2009 · NS · contact PI
Neurodevelopmental Effects of Antiepileptic Drugs II$964,017
R01 · FY2007 · NS · contact PI
Neurodevelopmental Effects of Antiepileptic Drugs II$1,033,768
R01 · FY2006 · NS · contact PI
COMPARISON OF COGNITIVE, BEHAVIORAL EFFECTS OF LEVETIRACETAM, CARBAMAZEPINE$2,065
M01 · FY2006 · RR · contact PI
Neurodevelopmental Effects of Antiepileptic Drugs II$1,108,968
R01 · FY2005 · NS
Neurodevelopmental Effects of Antiepileptic Drugs II$52,627
R01 · FY2005 · NS
COGNITIVE &BEHAVIORAL EFFECTS OF LEVETIRACETAM &CARBAMAZEPINE IN HEALTHY ADULT$23,297
M01 · FY2005 · RR
NEURODEVELOPMENTAL EFFECTS OF ANTIEPILEPTIC DRUGS (NEAD STUDY)$3,882
M01 · FY2005 · RR
NEURODEVELOPMENT EFFECTS OF ANTIEPILEPTIC DRUGS$1,470,138
R01 · FY2004 · NS
Comparison of the cognitive and behavioral effects of levetiracetam and carbamaz$1,052
M01 · FY2004 · RR
Neurodevelopmental effects of antiepileptic drugs (NEAD study)$702
M01 · FY2004 · RR
NEURODEVELOPMENT EFFECTS OF ANTIEPILEPTIC DRUGS$1,370,796
R01 · FY2003 · NS
NEURODEVELOPMENT EFFECTS OF ANTIEPILEPTIC DRUGS$1,391,286
R01 · FY2002 · NS
NEURODEVELOPMENT EFFECTS OF ANTIEPILEPTIC DRUGS$1,367,312
R01 · FY2001 · NS
NEURODEVELOPMENT EFFECTS OF ANTIEPILEPTIC DRUGS$1,495,849
R01 · FY2000 · NS